Skip to Main Content

November 08, 2023   

Pharmaceutical Mergers Under the Microscope: The FTC and Justice Department’s 2022 “Future of Pharmaceuticals” Workshop

This Briefing is brought to you by AHLA’s Antitrust Practice Group.
  • November 08, 2023
  • H. Kristie Xian , Jones Day
  • Macklin Willigan , Jones Day

On June 1, 2023, the Federal Trade Commission (FTC) and the U.S. Department of Justice’s Antitrust Division (DOJ) issued a summary of their June 2022 virtual workshop, “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers” (Workshop). This summary outlines how program participants—unified by their skepticism of pharmaceutical mergers and pro-enforcement perspectives—discussed new regulatory approaches to these mergers and provided recommendations “that will inform [the FTC’s] competition analysis and enforcement guidance in pharmaceutical markets going forward.”

ARTICLE TAGS

You must be logged in to access this content.